PubMed

Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients.

Avignon A, Sultan A, Piot C, Mariano-Goulart D, Thuan Dit Dieudonné JF, Cristol JP, Dupuy AM.

Diabetes Care. 2007 Nov;30(11):2934-9. Epub 2007 Aug 21.PMID: 17712025 [PubMed - indexed for MEDLINE]Related articlesFree article

Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients.

Avignon A, Sultan A, Piot C, Elaerts S, Cristol JP, Dupuy AM.

Diabetes Care. 2005 Sep;28(9):2176-80.PMID: 16123486 [PubMed - indexed for MEDLINE]Related articlesFree article

Silent myocardial ischemia in patients with diabetes: who to screen.

Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V.

Diabetes Care. 1999 Sep;22(9):1396-400.PMID: 10480499 [PubMed - indexed for MEDLINE]Related articlesFree article

Homocysteine concentrations in type 2 diabetic patients with silent myocardial ischemia: a predictive marker.

Tarkun I, Cetinarslan B, Cantürk Z, Tarkun P, Agaçdiken A, Komsuoglu B.

J Diabetes Complications. 2004 May-Jun;18(3):165-8.PMID: 15145328 [PubMed - indexed for MEDLINE]Related articles

Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study.

Valensi P, Pariès J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Maréchaud R, Estour B, Halimi S.

Diabetes Care. 2005 Nov;28(11):2722-7.PMID: 16249546 [PubMed - indexed for MEDLINE]Related articlesFree article

Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

Cosson E, Guimfack M, Paries J, Paycha F, Attali JR, Valensi P.

Diabetes Metab. 2003 Nov;29(5):470-6.PMID: 14631323 [PubMed - indexed for MEDLINE]Related articlesFree article

Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.

Torremocha F, Hadjadj S, Carrié F, Rosenberg T, Herpin D, Maréchaud R.

Diabetes Metab. 2001 Feb;27(1):49-57.PMID: 11240446 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia.

Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR.

Diabetes Care. 2001 Feb;24(2):339-43.PMID: 11213889 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test.

Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V.

Eur J Endocrinol. 2002 Nov;147(5):649-54.PMID: 12444897 [PubMed - indexed for MEDLINE]Related articlesFree article

Markers for silent myocardial ischemia in diabetes. Are they helpful?

Cosson E, Attali JR, Valensi P.

Diabetes Metab. 2005 Apr;31(2):205-13.PMID: 15959427 [PubMed - indexed for MEDLINE]Related articlesFree article

High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus.

Hsieh MC, Tien KJ, Chang SJ, Perng DS, Hsiao JY, Chen YW, Chang YH, Kuo HW, Lin PC.

Metabolism. 2008 Nov;57(11):1533-8.PMID: 18940390 [PubMed - indexed for MEDLINE]Related articles

Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.

Albertini JP, Valensi P, Lormeau B, Vaysse J, Attali JR, Gattegno L.

Diabetes Care. 1999 Dec;22(12):2044-8.PMID: 10587840 [PubMed - indexed for MEDLINE]Related articlesFree article

Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes.

Le Feuvre CL, Barthélémy O, Dubois-Laforgue D, Maunoury Ch, Mogenet A, Baubion N, Metzger JP, Timsit J.

Diabetes Metab. 2005 Apr;31(2):135-42.PMID: 15959419 [PubMed - indexed for MEDLINE]Related articlesFree article

[Elevated serum high sensitivity C-reactive protein and endothelial dysfunction in silent myocardial ischemia]

Jia FP, Lei H, Qin S, Ma KH, Liao H.

Zhonghua Nei Ke Za Zhi. 2007 Nov;46(11):919-22. Chinese. PMID: 18261275 [PubMed - indexed for MEDLINE]Related articles

Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes.

Rutter MK, Wahid ST, McComb JM, Marshall SM.

J Am Coll Cardiol. 2002 Jul 3;40(1):56-61.PMID: 12103256 [PubMed - indexed for MEDLINE]Related articles

Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients.

Sultan A, Avignon A, Galtier F, Piot C, Mariano-Goulart D, Dupuy AM, Cristol JP.

Diabetes Care. 2008 Mar;31(3):593-5. Epub 2007 Dec 14. No abstract available. PMID: 18083791 [PubMed - indexed for MEDLINE]Related articlesFree article

Determinants of echocardiographically measured left ventricular mass in diabetic patients with or without silent myocardial ischaemia.

Sachs RN, Valensi P, Lormeau B, Taupin JM, Nitenberg A, Metz D, Talvard O, Paries J, Dali M, Leutenegger M, Attali JR.

Diabetes Metab. 1999 Jun;25(2):128-36.PMID: 10443323 [PubMed - indexed for MEDLINE]Related articlesFree article

Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.

Godsland IF, Elkeles RS, Feher MD, Nugara F, Rubens MB, Richmond W, Khan M, Donovan J, Anyaoku V, Flather MD; PREDICT Study Group.

Diabet Med. 2006 Nov;23(11):1192-200.PMID: 17054594 [PubMed - indexed for MEDLINE]Related articles

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.

Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.

Diabetologia. 2008 Nov;51(11):2100-7. Epub 2008 Aug 22.PMID: 18719882 [PubMed - indexed for MEDLINE]Related articles

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.

Gannagé-Yared MH, Yaghi C, Habre B, Khalife S, Noun R, Germanos-Haddad M, Trak-Smayra V.

Eur J Endocrinol. 2008 Mar;158(3):353-9.PMID: 18299469 [PubMed - indexed for MEDLINE]Related articlesFree article